Trials of the Sputnik V Covid-19 vaccine in India will be backed by the government after a local company which has partnered with Russia for testing signed a cooperation agreement with the authorities.

Dr. Reddy’s pharmaceutical company announced on Thursday that it will receive “advisory support on clinical trials of Sputnik V vaccine” from the Indian government’s Department of Biotechnology through its Biotechnology Industry Research Assistance Council (BIRAC).

The agreement with BIRAC will grant the company, which works hand-in-hand with the Russia Direct Investment Fund (RDIF), access to government-funded clinical trial centers and laboratories to conduct immunogenicity assay testing of the vaccine. (RT)